Secretome Therapeutics raises $30.0M Series A (United States, May 2026)
$30.0M
$30M Series AGenerated social card
Headline
Secretome Therapeutics Raises $30M Series A for Cardiac Cell Therapy Expansion - Ventureburn
About
Secretome Therapeutics is focused on developing regenerative cardiac therapies, particularly targeting conditions like Duchenne muscular dystrophy associated cardiomyopathy. The company aims to restore and regenerate cardiac function through innovative cellular therapies, with recent funding set to advance their clinical trials and manufacturing capabilities.
Article summary
Secretome Therapeutics Raises $30M Series A for Cardiac Cell Therapy Expansion Ventureburn
Investors · 1
RA Capital ManagementLead
FUND
Related rounds
| May 28, 2026 | Reactor | $59.0M | — | United States |
| May 28, 2026 | Rosarium Health | $6.0M | Seed | United States |
| May 28, 2026 | Solstice | $21.0M | Series A | United States |
| May 28, 2026 | LightTable | $22.0M | Series A | United States |